What we offer

End-to-end partnership from late stage Phase 2 clinical trials through Loss of Exclusivity (LOE) with technology-enabled solutions that are more effective and sustainable than conventional methods

Who is it for

CXO and executive leadership team of emerging biotech companies

Why it’s important

Single, expert partner to manage many complex processes

Launch your product for sustained profitability

Ensure business and innovation survives and thrives

How we deliver

Process

We understand your strategic vision and collaborate to execute it swiftly.

We apply our industry expertise and a digital-first approach to ensure clinical trials are completed quickly and successfully. We help secure regulatory approvals, produce commercial content, ensure physicians know how and when to prescribe your product, patients have access to it and the product is accurately labeled and priced.

Throughout the life cycle, we evangelize the product’s benefits through an omnichannel approach. As true partners, we put skin in the game and share your risks.

What makes us different

Solution created by and for emerging biotech

More equitable commercial structure

Proven technology IP for a digital-first approach

Technology Type: NEXT HCP Journey Optimization, NEXT Clinical Trials Design, NEXT Medical Information, NEXT MLR Review Automation, NEXT Commercial Content Intelligence